Sepideh Elyasi

20PUBLICATIONS
15CO-AUTHORS
Medical infection agents (incl. prions)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - amino acids and metabolitesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jul 26, 2026
Combination of Oral Doxycycline and Rifampin for Pan-Drug Resistant Klebsiella pneumoniae Infection: A Case Report.

|Aug 05, 2025
Promising efficacy of oral nano-silymarin formulation on prevention of vancomycin-induced nephrotoxicity: a randomized, triple-blinded, placebo-controlled clinical trial.

Vahid Soleimani, Rozita Khodashahi, Mahnaz Arian

|Mar 11, 2025
Evaluation of Oral Nano-Silymarin Formulation Efficacy in the Prevention of Hand-Foot Syndrome and Neuropathy Induced by XELOX or m-FOLFOX6 Regimens in Metastatic Colorectal Cancer: A Triple-Blinded, Randomized Clinical Trial.

Hedyieh Karbasforooshan, Hossein Rahimi, Omid Arasteh

|Sep 03, 2024
"The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial".

Mehdi Tohidi, Abolghasem Allahyari, Sajjad Ataei Azimi

|Aug 07, 2024
Evaluation of oral silymarin formulation efficacy in prevention of doxorubicin induced hepatotoxicity in patients with non-metastatic breast cancer.

Ashkan Fatemi Shandiz, Gholamreza Karimi, Mahdiyeh Dayyani

|Apr 12, 2024
Albumin: a comprehensive review and practical guideline for clinical use.

Farshad Abedi, Batool Zarei, Sepideh Elyasi

Pageof 4

Frequent Collaborators

1 joint publications

Amir Hooshang Mohammadpour

1 joint publications

Zhila Taherzadeh

1 joint publications

Seyed Alireza Javadinia

1 joint publications

Sare Hosseini